Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
65
UMBF Quote, Financials, Valuation and Earnings
Last price:
$134.24
Seasonality move
:
4.1%
Day range:
$133.44 - $136.11
52-week range:
$82.00 - $136.11
Dividend yield:
1.21%
P/E ratio:
14.70x
P/S ratio:
2.40x
P/B ratio:
1.38x
Volume:
711.9K
Avg. volume:
524.3K
1-year change:
15.45%
Market cap:
$10.2B
Revenue:
$4.1B
EPS (TTM):
$9.14
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.7B | $2.4B | $2.8B | $4.1B | |
| Revenue Growth (YoY) | 6.09% | 27.64% | 40.28% | 17.49% | 47.97% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $5.1M | $58.4M | -$3.1M | $10.7M | -- | |
| Operating Expenses | -$431.8M | -$532M | -$426.5M | -$541.3M | -$875M | |
| Operating Income | $431.8M | $532M | $426.5M | $541.3M | $875M | |
| Net Interest Expenses | $12.7M | $15.5M | $121.4M | $81.3M | -- | |
| EBT. Incl. Unusual Items | $429.1M | $532M | $421.6M | $541.3M | $875M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $76M | $100.3M | $71.6M | $100M | $172.6M | |
| Net Income to Company | $353M | $431.7M | $350M | $441.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $353M | $431.7M | $350M | $441.2M | $702.4M | |
| Basic EPS (Cont. Ops) | $7.31 | $8.93 | $7.22 | $9.05 | $9.35 | |
| Diluted EPS (Cont. Ops) | $7.24 | $8.86 | $7.18 | $8.99 | $9.29 | |
| Weighted Average Basic Share | $48.3M | $48.3M | $48.5M | $48.7M | $73.3M | |
| Weighted Average Diluted Share | $48.7M | $48.7M | $48.8M | $49.1M | $73.7M | |
| EBITDA | -- | $809.8M | $1.4B | $1.8B | -- | |
| EBIT | $475.1M | $755.7M | $1.3B | $1.7B | $2.4B | |
| Revenue (Reported) | $1.3B | $1.7B | $2.4B | $2.8B | $4.1B | |
| Operating Income (Reported) | $431.8M | $532M | $426.5M | $541.3M | $875M | |
| Operating Income (Adjusted) | $475.1M | $755.7M | $1.3B | $1.7B | $2.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $340.4M | $492.7M | $636.9M | $720.2M | $1.1B | |
| Revenue Growth (YoY) | -21.86% | 44.76% | 29.25% | 13.08% | 50.69% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.4M | -$409K | $1M | $593K | -- | |
| Operating Expenses | -$98.4M | -$123.8M | -$80.8M | -$144.8M | -$270.3M | |
| Operating Income | $98.4M | $123.8M | $80.8M | $144.8M | $270.3M | |
| Net Interest Expenses | $3M | $5.3M | -- | $6.9M | -- | |
| EBT. Incl. Unusual Items | $98.4M | $123.8M | $80.8M | $144.8M | $270.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.9M | $23.7M | $9.9M | $24.8M | $55M | |
| Net Income to Company | $78.5M | $100.2M | $70.9M | $120M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $78.5M | $100.2M | $70.9M | $120M | $215.4M | |
| Basic EPS (Cont. Ops) | $1.62 | $2.07 | $1.46 | $2.46 | $2.76 | |
| Diluted EPS (Cont. Ops) | $1.61 | $2.06 | $1.45 | $2.44 | $2.74 | |
| Weighted Average Basic Share | $48.4M | $48.3M | $48.5M | $48.8M | $76M | |
| Weighted Average Diluted Share | $48.9M | $48.7M | $48.9M | $49.2M | $76.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $109.4M | $245.5M | $346.9M | $430.8M | $634.7M | |
| Revenue (Reported) | $340.4M | $492.7M | $636.9M | $720.2M | $1.1B | |
| Operating Income (Reported) | $98.4M | $123.8M | $80.8M | $144.8M | $270.3M | |
| Operating Income (Adjusted) | $109.4M | $245.5M | $346.9M | $430.8M | $634.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.7B | $2.4B | $2.8B | $4.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $5.1M | $58.4M | -$3.1M | $10.7M | -- | |
| Operating Expenses | -$432.5M | -$532M | -$421.9M | -$531.6M | -$875M | |
| Operating Income | $432.5M | $532M | $421.9M | $531.6M | $875M | |
| Net Interest Expenses | $12.7M | $15.5M | $91M | $81.3M | $36.4M | |
| EBT. Incl. Unusual Items | $429.1M | $532M | $421.6M | $541.3M | $875M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $76M | $100.3M | $71.6M | $100M | $172.6M | |
| Net Income to Company | $353M | $431.7M | $350M | $441.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $353M | $431.7M | $350M | $441.2M | $702.4M | |
| Basic EPS (Cont. Ops) | $7.31 | $8.93 | $7.22 | $9.05 | $9.19 | |
| Diluted EPS (Cont. Ops) | $7.25 | $8.86 | $7.18 | $9.00 | $9.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $475.1M | $755.7M | $1.3B | $1.7B | $2.4B | |
| Revenue (Reported) | $1.3B | $1.7B | $2.4B | $2.8B | $4.1B | |
| Operating Income (Reported) | $432.5M | $532M | $421.9M | $531.6M | $875M | |
| Operating Income (Adjusted) | $475.1M | $755.7M | $1.3B | $1.7B | $2.4B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $2.4B | $2.8B | $4.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $58.4M | -$3.1M | $10.7M | $32.9M | -- | |
| Operating Expenses | -$532M | -$421.9M | -$531.6M | -$875M | -- | |
| Operating Income | $532M | $421.9M | $531.6M | $875M | -- | |
| Net Interest Expenses | $15.5M | $91M | $81.3M | $36.4M | -- | |
| EBT. Incl. Unusual Items | $532M | $421.6M | $541.3M | $875M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $100.3M | $71.6M | $100M | $172.6M | -- | |
| Net Income to Company | $431.7M | $350M | $441.2M | $298.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $431.7M | $350M | $441.2M | $702.4M | -- | |
| Basic EPS (Cont. Ops) | $8.93 | $7.22 | $9.05 | $9.19 | -- | |
| Diluted EPS (Cont. Ops) | $8.86 | $7.18 | $9.00 | $9.14 | -- | |
| Weighted Average Basic Share | $193.4M | $194M | $195M | $292.9M | -- | |
| Weighted Average Diluted Share | $194.9M | $195M | $196.2M | $294.5M | -- | |
| EBITDA | $150.4M | $294M | $428.3M | $462.7M | -- | |
| EBIT | $755.7M | $1.3B | $1.7B | $2.4B | -- | |
| Revenue (Reported) | $1.7B | $2.4B | $2.8B | $4.1B | -- | |
| Operating Income (Reported) | $532M | $421.9M | $531.6M | $875M | -- | |
| Operating Income (Adjusted) | $755.7M | $1.3B | $1.7B | $2.4B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.2B | $1.6B | $5.5B | $8.4B | $952.5M | |
| Short Term Investments | $12B | $7B | $7.1B | $7.8B | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.7B | $2.9B | $6.2B | $9.5B | $9.8B | |
| Property Plant And Equipment | $328M | $318.2M | $291.7M | $269.4M | $398.3M | |
| Long-Term Investments | $363.1M | $511M | $726.4M | $807.4M | $7.6B | |
| Goodwill | $174.5M | $207.4M | $207.4M | $207.4M | -- | |
| Other Intangibles | $67.2M | $124.4M | $101.4M | $80.8M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $42.8B | $38.6B | $44.1B | $50.5B | $73.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $249.5M | $239.6M | $389.9M | $368.5M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $1B | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $19.6B | $16.3B | $39.5B | $16.2B | $20.9B | |
| Long-Term Debt | $327.7M | $432.5M | $430.2M | $433.3M | $474.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $39.6B | $35.9B | $41B | $47B | $65.4B | |
| Common Stock | $55.1M | $55.1M | $55.1M | $55.1M | $78.7M | |
| Other Common Equity Adj | $126.3M | -$702.7M | -$556.9M | -$573.1M | -- | |
| Common Equity | $3.1B | $2.7B | $3.1B | $3.5B | $7.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.1B | $2.7B | $3.1B | $3.5B | $7.7B | |
| Total Liabilities and Equity | $42.8B | $38.6B | $44.1B | $50.5B | $73.1B | |
| Cash and Short Terms | $21.2B | $8.7B | $12.7B | $16.3B | -- | |
| Total Debt | $327.7M | $432.5M | $430.2M | $433.3M | $474.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.2B | $1.6B | $5.5B | $8.4B | $952.5M | |
| Short Term Investments | $12B | $7B | $7.1B | $7.8B | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.7B | $2.9B | $6.2B | $9.5B | $9.8B | |
| Property Plant And Equipment | $328M | $318.2M | $291.7M | $269.4M | $398.3M | |
| Long-Term Investments | $363.1M | $511M | $726.4M | $807.4M | $7.6B | |
| Goodwill | $174.5M | $207.4M | $207.4M | $207.4M | -- | |
| Other Intangibles | $67.2M | $124.4M | $101.4M | $80.8M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $42.8B | $38.6B | $44.1B | $50.5B | $73.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $249.5M | $239.6M | $389.9M | $368.5M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $1B | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $19.6B | $16.3B | $39.5B | $16.2B | $20.9B | |
| Long-Term Debt | $327.7M | $432.5M | $430.2M | $433.3M | $474.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $39.6B | $35.9B | $41B | $47B | $65.4B | |
| Common Stock | $55.1M | $55.1M | $55.1M | $55.1M | $78.7M | |
| Other Common Equity Adj | $126.3M | -$702.7M | -$556.9M | -$573.1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.1B | $2.7B | $3.1B | $3.5B | $7.7B | |
| Total Liabilities and Equity | $42.8B | $38.6B | $44.1B | $50.5B | $73.1B | |
| Cash and Short Terms | $21.2B | $8.7B | $12.7B | $16.3B | -- | |
| Total Debt | $327.7M | $432.5M | $430.2M | $433.3M | $474.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286.5M | $353M | $431.7M | $350M | $441.2M | |
| Depreciation & Amoritzation | $62.8M | $55.7M | $54M | $58.7M | $52.8M | |
| Stock-Based Compensation | $15.1M | $21.2M | $21.5M | $18.7M | $22.6M | |
| Change in Accounts Receivable | -$15.4M | $4.6M | -$58.2M | -$31.1M | -$24.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $229.8M | $396.5M | $707.5M | $404.8M | $144.7M | |
| Capital Expenditures | $160.2M | $133.7M | $51.7M | $29.9M | $24.2M | |
| Cash Acquisitions | -- | -- | -- | $793K | $109M | |
| Cash From Investing | -$4.3B | -$4.1B | -$3.8B | -$1.2B | -$3.2B | |
| Dividends Paid (Ex Special Dividend) | $60.3M | $66.8M | $72M | $74.2M | $77.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $215M | -- | $110M | $32.9B | $500M | |
| Long-Term Debt Repaid | -$15M | -- | -- | -$31.1B | -$2.3B | |
| Repurchase of Common Stock | $63.8M | $5.5M | $32M | $8.4M | $7.7M | |
| Other Financing Activities | -$2.3M | -- | -$2.1M | -- | -$1.4M | |
| Cash From Financing | $5.9B | $9.4B | -$4.6B | $4.8B | $6B | |
| Beginning Cash (CF) | $1.7B | $3.5B | $9.2B | $1.6B | $5.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8B | $5.7B | -$7.7B | $4B | $2.9B | |
| Ending Cash (CF) | $3.5B | $9.2B | $1.6B | $5.5B | $8.4B | |
| Levered Free Cash Flow | $69.6M | $262.8M | $655.8M | $374.9M | $120.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $78.5M | $100.2M | $70.9M | $120M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $7.1M | $4.8M | $6M | $7M | -- | |
| Change in Accounts Receivable | -$8.3M | -$35.5M | -$11.7M | -$27.4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $105.6M | $133.6M | $60.3M | -$104.5M | -- | |
| Capital Expenditures | $13M | $17.4M | $6.8M | $10.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.1B | -$926.1M | -$642.3M | -$1.7B | -- | |
| Dividends Paid (Ex Special Dividend) | $17.9M | $18.4M | $18.9M | $19.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$500M | -$1.1B | -- | |
| Repurchase of Common Stock | $1.2M | $191K | $271K | -- | -- | |
| Other Financing Activities | -- | -$97K | -- | -$64K | -- | |
| Cash From Financing | $5.1B | $339.9M | $2.2B | $3B | -- | |
| Beginning Cash (CF) | $6.1B | $2B | $3.9B | $7.3B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.1B | -$452.6M | $1.6B | $1.2B | -- | |
| Ending Cash (CF) | $9.2B | $1.6B | $5.5B | $8.4B | -- | |
| Levered Free Cash Flow | $92.6M | $116.2M | $53.5M | -$114.7M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $353M | $431.7M | $350M | $441.2M | -- | |
| Depreciation & Amoritzation | $55.7M | $54M | $58.7M | $52.8M | -- | |
| Stock-Based Compensation | $21.2M | $21.5M | $18.7M | $22.6M | -- | |
| Change in Accounts Receivable | $4.6M | -$58.2M | -$31.1M | -$24.6M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $396.5M | $707.5M | $404.8M | $205.4M | -- | |
| Capital Expenditures | $133.7M | $51.7M | $29.9M | $24.2M | $37.8M | |
| Cash Acquisitions | -- | -- | $793K | $109M | -- | |
| Cash From Investing | -$4.1B | -$3.8B | -$1.2B | -$3.2B | -- | |
| Dividends Paid (Ex Special Dividend) | $66.8M | $72M | $74.2M | $77.1M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $110M | $32.9B | $500M | -- | |
| Long-Term Debt Repaid | -- | -- | -$31.1B | -$2.3B | -- | |
| Repurchase of Common Stock | $5.5M | $32M | $8.4M | $7.7M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $9.4B | -$4.6B | $4.8B | $6B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5.7B | -$7.7B | $4B | $2.9B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $262.8M | $655.8M | $374.9M | $181.2M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $431.7M | $350M | $441.2M | $298.7M | -- | |
| Depreciation & Amoritzation | $13.2M | $15.4M | $13.8M | $67.4M | -- | |
| Stock-Based Compensation | $21.5M | $18.7M | $22.6M | $28.4M | -- | |
| Change in Accounts Receivable | -$58.2M | -$31.1M | -$24.6M | -$7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $707.5M | $404.8M | $205.4M | $927.9M | -- | |
| Capital Expenditures | $51.7M | $29.9M | $24.2M | $37.8M | -- | |
| Cash Acquisitions | -- | $793K | $109M | -- | -- | |
| Cash From Investing | -$3.8B | -$1.2B | -$3.2B | -$3.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $72M | $74.2M | $77.1M | $95M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $110M | $32.9B | $500M | -- | -- | |
| Long-Term Debt Repaid | -- | -$31.1B | -$2.3B | -$11.1M | -- | |
| Repurchase of Common Stock | $32M | $8.4M | $7.7M | $132.5M | -- | |
| Other Financing Activities | -$2.1M | -- | -$1.4M | -- | -- | |
| Cash From Financing | -$4.6B | $4.8B | $6B | $2.9B | -- | |
| Beginning Cash (CF) | $20B | $12.7B | $24.8B | $19.1B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$7.7B | $4B | $2.9B | $392.7M | -- | |
| Ending Cash (CF) | $12.4B | $16.7B | $27.7B | $21.6B | -- | |
| Levered Free Cash Flow | $655.8M | $374.9M | $181.2M | $890.1M | -- | |
Get UMBF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UMBF
Sector
P/E ratio
14.70x
12.54x
PEG ratio
9.39x
0.32x
P/B ratio
1.38x
1.15x
Price / LTM sales
2.40x
1.86x
Growth Metrics
UMBF
Sector
Revenue growth
50.69%
5.54%
Earnings growth
12.3%
11.36%
Revenue (5-year growth)
26.99%
8.68%
Earnings forecast
$2.70
$0.64
Profitability
UMBF
Sector
Profitability FY 2025
--
--
Return on invested capital
7.08%
5.2%
Return on assets
1.04%
1.03%
Return on equity
10.76%
9.91%
Earnings Date
Last Earnings Date
Jan
27
Next Earnings Date
Apr
28
Estimated Next Earnings Date
Apr
28
Balance Sheet
UMBF
Sector
Total cash
$11.4B
$407.2M
Short term investments
$7.8B
$192.4M
Total assets
$73.1B
$3.1B
Long term debt
$474.2M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 9
Bill Holdings, Inc. [BILL] is up 3.7% over the past day.
Buy
75
PRLB alert for Feb 9
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 9
Strategy, Inc. [MSTR] is up 2.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
